Vanguard Personalized Indexing Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.4M Sell
107,336
-18,253
-15% -$1.47M 0.07% 236
2026
Q1
$10.9M Sell
125,589
-5,225
-4% -$501K 0.11% 160
2025
Q4
$12.6M Buy
130,814
+64
+0% +$6.22K 0.12% 125
2025
Q3
$12.5M Buy
130,750
+10,716
+9% +$985K 0.13% 122
2025
Q2
$10.5M Buy
120,034
+7,643
+7% +$648K 0.12% 146
2025
Q1
$10.1M Buy
112,391
+17,587
+19% +$1.57M 0.15% 114
2024
Q4
$7.57M Buy
94,804
+5,624
+6% +$487K 0.11% 143
2024
Q3
$8.03M Buy
89,180
+886
+1% +$74.5K 0.13% 130
2024
Q2
$6.85M Buy
88,294
+20,666
+31% +$1.69M 0.13% 127
2024
Q1
$5.89M Buy
67,628
+9,950
+17% +$849K 0.13% 139
2023
Q4
$4.75M Sell
57,678
-7,268
-11% -$554K 0.12% 141
2023
Q3
$5.09M Sell
64,946
-6,764
-9% -$566K 0.15% 112
2023
Q2
$6.32M Buy
71,710
+6,648
+10% +$572K 0.19% 87
2023
Q1
$5.25M Buy
65,062
+34,146
+110% +$2.78M 0.18% 103
2022
Q4
$2.4M Sell
30,916
-16,234
-34% -$1.32M 0.1% 210
2022
Q3
$3.81M Buy
47,150
+7,027
+18% +$632K 0.17% 107
2022
Q2
$3.6M Sell
40,123
-5,311
-12% -$538K 0.17% 106
2022
Q1
$5.04M Buy
45,434
+24,856
+121% +$2.63M 0.24% 68
2021
Q4
$2.13M Sell
20,578
-10,969
-35% -$1.27M 0.13% 151
2021
Q3
$3.95M Buy
31,547
+4,345
+16% +$562K 0.36% 43
2021
Q2
$3.38M Buy
27,202
+10,164
+60% +$1.28M 0.35% 39
2021
Q1
$2.01M Buy
17,038
+6,283
+58% +$736K 0.3% 63
2020
Q4
$1.26M Buy
10,755
+1,549
+17% +$171K 0.27% 77
2020
Q3
$957K Buy
9,206
+4,932
+115% +$495K 0.27% 80
2020
Q2
$392K Sell
4,274
-1,255
-23% -$120K 0.18% 141
2020
Q1
$499K Buy
+5,529
New +$588K 0.29% 95

Other funds holding MDT

Vanguard Personalized Indexing Management's MDT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $1.47M and leaving 107,336 shares worth $8.4M. The position accounts for 0.07% of the portfolio, ranked #236.

Vanguard Personalized Indexing Management first reported a position in MDT in Q1 2020 and has held it in 26 quarters since. The position peaked at $12.6M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 107,336 shares of Medtronic worth $8.4M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 18,253 Medtronic shares in Q2 2026, an estimated $1.47M.
  • Medtronic made up 0.07% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #236 holding.
  • Vanguard Personalized Indexing Management first reported a position in Medtronic in Q1 2020 and has held it in 26 quarters since.
  • Vanguard Personalized Indexing Management's Medtronic position peaked at $12.6M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.